Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Low-grade Upper Tract Urothelial Cancer News

News
Low Compliance With Most Diagnostic Recommendations for Upper Tract Urothelial Carcinoma
10/20/2022
Maria Asimopoulos
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical guideline adherence in the management of upper tract urothelial carcinoma.
Study authors evaluated clinical...
10/20/2022
Integrated Healthcare Executive
News
Reviewing Association of UTUC Pathological Characteristics With Daily Fluid Intake, Behavioral Habits
10/12/2022
Edan Stanley
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative questionnaire survey, researchers analyzed the water drinking habits of patients with upper tract urothelial carcinoma and the connection to their pathological characteristics.
Through a preoperative...
10/12/2022
Veterans Health Today
News
In Vitro Study Explores Potential Feasibility of Mitomycin-Coated Biodegradable Ureteral Stent
10/03/2022
Edan Stanley
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to the coating of silk fibroin stents could be an attractive approach for intracavitary instillation in the upper urinary tract,” concluded researchers, noting that more research is needed.
“The addition of mitomycin C to...
10/03/2022
First Report Managed Care

Advertisement

News
Germline Mutation Screening in Patients With UTUC, Lynch Syndrome
09/20/2022
Edan Stanley
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma is the third most common cancer associated with Lynch syndrome; however, there is not an established guideline for identifying at patients with UTUC who are at risk of carrying germline mutations.
Upper tract urothelial carcinoma...
09/20/2022
Integrated Healthcare Executive
News
Avoiding Kidney Removal Among Patients With UTUC Through Chemoablation
08/19/2022
Edan Stanley
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding alternatives to kidney removal among patients with low-grade upper tract urothelial cancer is key to improving patient quality of life.
Data demonstrates finding...
08/19/2022
Integrated Healthcare Executive
News
Endoscopic Management Beneficial But Costly for Low-Grade Upper Tract Urothelial Carcinoma
08/18/2022
Samantha Matthews
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic management for low-grade upper tract urothelial carcinoma as a valid option from oncological aspects but highlight the associated costs,” wrote researchers.
“Our findings support endoscopic...
08/18/2022
Veterans Health Today

Advertisement

News
Addressing Unmet Needs for Patients With Low-grade Upper Tract Urothelial Carcinoma
08/17/2022
Edan Stanley
Despite being one of the most common types of bladder cancer, urothelial carcinoma presents several challenges to patients due to the diseases’ tendency to expand and spread cells to other parts of the urinary tract, including the kidney.
Despite being one of the most common types of bladder cancer, urothelial carcinoma presents several challenges to patients due to the diseases’ tendency to expand and spread cells to other parts of the urinary tract, including the kidney.
Despite being one of the most...
08/17/2022
First Report Managed Care
News
Urothelial Carcinoma Molecular Subtype Could Guide Use of Neoadjuvant Chemotherapy
08/09/2022
Jolynn Tumolo
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated with different rates of complete pathological response in patients with urothelial carcinoma.
Cancer subtype was associated...
08/09/2022
First Report Managed Care
News
FDA Approves Sacituzumab Govitecan for Advanced Urothelial Cancer
04/13/2021
The FDA has granted accelerated approval to sacituzumab govitecan for the treatment of certain adults with locally advanced or metastatic urothelial cancer.
The FDA has granted accelerated approval to sacituzumab govitecan for the treatment of certain adults with locally advanced or metastatic urothelial cancer.
The FDA has granted accelerated...
04/13/2021
Oncology

Advertisement

News
FDA Approves Avelumab for Advanced or Metastatic Urothelial Carcinoma
07/01/2020
The FDA approved avelumab for the first-line maintenance treatment of patients with locally advanced metastatic or urothelial carcinoma who have not progressed on first-line platinum-containing chemotherapy.
The FDA approved avelumab for the first-line maintenance treatment of patients with locally advanced metastatic or urothelial carcinoma who have not progressed on first-line platinum-containing chemotherapy.
The FDA approved avelumab for...
07/01/2020
Oncology

Advertisement

Advertisement

Advertisement

What's Trending?

News Connection
Patients’ Use of Multiple Acute Care Facilities
02/15/2011

Tori Socha

Tori Socha
Timely access to patients’ health information is a key component in delivering effective and safe medical treatment.
Timely access to patients’ health information is a key component in delivering effective and safe medical treatment.
Timely access to patients’...
02/15/2011
First Report Managed Care
News
TAVR may help recovery of cognitive function
10/19/2016
By David DouglasNEW YORK (Reuters Health) -...
By David DouglasNEW YORK (Reuters Health) -...
...
10/19/2016
Population Health
News
FDA Approves New Drug to Treat Irritable Bowel Syndrome and Constipation
10/16/2012
On August 30, 2012, the FDA approved Linzess (linaclotide) for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults. Constipation is one of the most common gastrointestinal...
On August 30, 2012, the FDA approved Linzess (linaclotide) for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults. Constipation is one of the most common gastrointestinal...
On August 30, 2012, the FDA...
10/16/2012
Annals of Long-Term Care
Conference Insider
Zarxio Switching Fails to Meet Budget Impact Model Expectations
05/10/2017
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented...
05/10/2017
First Report Managed Care
News
Welcome to the AES 2017 Annual Meeting
11/29/2017
The 71st American Epilepsy Society (AES) Annual Meeting is taking place in Washington, DC, from December 1st through December 5th at the Walter E Washington Convention Center.
The 71st American Epilepsy Society (AES) Annual Meeting is taking place in Washington, DC, from December 1st through December 5th at the Walter E Washington Convention Center.
The 71st American Epilepsy...
11/29/2017
Annals of Long-Term Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use